NORVIR 100 MG
RITONAVIR : 100 MG · DIN 02229137 · ABBVIE CORPORATION
Health Canada status: CANCELLED POST MARKET
What is NORVIR?
NORVIR 100 MG contains RITONAVIR : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02229137, held by ABBVIE CORPORATION, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 08-Nov-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is NORVIR called?
Also recorded in Canada as: {20 (nirmatrelvir 150 MG Oral Tablet) / 10 (ritonavir 100 MG Oral Tablet) } Pack [Paxlovid 5-Day] (US), {10 (nirmatrelvir 150 MG Oral Tablet) / 10 (ritonavir 100 MG Oral Tablet) } Pack [Paxlovid 150 MG /100 MG Dose Pack] (US), {20 (nirmatrelvir 150 MG Oral Tablet) / 10 (ritonavir 100 MG Oral Tablet) } Pack (US), {10 (nirmatrelvir 150 MG Oral Tablet) / 10 (ritonavir 100 MG Oral Tablet) } Pack (US), {6 (nirmatrelvir 150 MG Oral Tablet) / 5 (ritonavir 100 MG Oral Tablet) } Pack (US), ritonavir 100 MG Oral Capsule [Norvir] (US), ritonavir 100 MG Oral Powder [Norvir] (US), lopinavir 200 MG / ritonavir 50 MG Oral Tablet [Kaletra] (US), lopinavir 100 MG / ritonavir 25 MG Oral Tablet [Kaletra] (US), lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Solution [Kaletra] (US), ritonavir 100 MG Oral Tablet [Norvir] (US), ombitasvir 12.5 MG / paritaprevir 75 MG / ritonavir 50 MG Oral Tablet (US), ritonavir 100 MG Oral Powder (US), ritonavir 80 MG/ML Oral Solution (US), lopinavir 133 MG / ritonavir 33.3 MG Oral Capsule (US).
The same molecule, RITONAVIR, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| RITONAVIR | Latin | Brazil |
| Ritonavir Viatris | Latin | Sweden |
| Norvir Oral Powder | Latin | South Africa |
| Norvir® | Latin | United Arab Emirates |
| Paxlovid | Latin | Saudi Arabia |
| Rinavo | Latin | South Africa |
| Ritonavir Accord | Latin | Sweden |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02229137 |
|---|---|
| Brand name | NORVIR |
| Generic / active ingredient | RITONAVIR : 100 MG |
| Manufacturer | ABBVIE CORPORATION |
| Strength | 100 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J05AE03 RITONAVIR |
| AHFS class | 08:18.08.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 08-Nov-2012 |
| Original market date | 1996-09-16 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02229137 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2229137 |
| Brand name | NORVIR |
| Active ingredient / INN | RITONAVIR : 100 MG |
| ATC code | J05AE03 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J05 |
| AHFS class | 08:18.08.08 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | ABBVIE CORPORATION |
Which pack is which?
| Strength on the label | 100 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code J05AE03 RITONAVIR. 2 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-RITONAVIR | 100 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02523620 |
| NORVIR | 100 MG | TABLET | ABBVIE CORPORATION | MARKETED | DIN 02357593 |
| NORVIR | 80 MG | SOLUTION | ABBVIE CORPORATION | CANCELLED POST MARKET | DIN 02229145 |
| NORVIR SEC | 100 MG | CAPSULE | ABBVIE CORPORATION | CANCELLED POST MARKET | DIN 02241480 |
Who else supplies RITONAVIR worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. RITONAVIR appears in 33 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does RITONAVIR cost around the world?
RITONAVIR is listed on 12 national price registers Nexara tracks, across 36 pack listings published on 11 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Sweden | AIP (pharmacy purchase price) | 3 | 7 | 03 Sep 2026 |
| South Africa | single exit price | 6 | 6 | 01 Sep 2026 |
| United States | acquisition | 1 | 5 | 03 Sep 2026 |
| Italy | ex-factory (classe H) | 3 | 4 | 02 Sep 2026 |
| Romania | max producer price | 3 | 4 | 03 Sep 2026 |
| Brazil | preco fabrica (ex-factory ceiling) | 2 | 3 | 02 Sep 2026 |
| Saudi Arabia | public | 2 | 2 | 01 Sep 2026 |
| United Arab Emirates | public | 1 | 1 | 31 Aug 2026 |
| Australia | ex-manufacturer | 1 | 1 | 08 Sep 2026 |
| Greece | producer price (ex-factory) | 1 | 1 | 03 Sep 2026 |
| Norway | max AUP (pharmacy retail) | 1 | 1 | 07 Sep 2026 |
| Slovakia | categorised final price | 1 | 1 | 02 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.